NSAIDS inhibit the IL-1β-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2
- 1 November 1997
- journal article
- Published by Elsevier in Brain Research
- Vol. 777 (1-2) , 210-218
- https://doi.org/10.1016/s0006-8993(97)01204-3
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymesTrends in Pharmacological Sciences, 1997
- Do Nonsteroidal Anti-Inflammatory Drugs Have a Protective Effect Against Dementia?Drugs & Aging, 1996
- Amyloid β Protein Primes Cultured Rat Microglial Cells for an Enhanced Phorbol 12‐Myristate 13‐Acetate‐Induced Respiratory Burst ActivityJournal of Neurochemistry, 1996
- New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and causeNeurobiology of Aging, 1994
- Activated microglia and cerebral amyloid deposits in alzheimer's diseaseResearch in Immunology, 1992
- Distribution pattern and functional state of complement proteins and α-antichymotrypsin in cerebral β/A4 deposits in Alzheimer's diseaseResearch in Immunology, 1992
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated ‘acute phase response’ in the brain?Immunology Today, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Dexamethasone regulation of the expression of cytokine mRNAs induced by interleukin‐1 in the astrocytoma cell line U373MGFEBS Letters, 1989